Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antonieta Salud Salvia, MD
Hospital Universitari Arnau de Vilanova de Lleida
Principal Investigator - Antonio Cubillo, MD
Hospital Universitario Madrid Sanchinarro (CIOCC)
Principal Investigator - Bertomeu Massuti, MD
Hospital General Universitario de Alicante
Principal Investigator - Carles Pericay Pijaume, MD
Hospital de Sabadell - Parc Taulí
Principal Investigator - Carlos Fernández-Martos, MD
Fundación Instituto Valenciano de Oncología
Study Director - Carlos López López, MD
Hospital Universitario Marqués de Valdecilla
Principal Investigator - Clara Montagut, MD
Hospital del Mar
Principal Investigator - Ferrán Losa, MD
Hospital de Sant Joan Despí Moisés Broggi
Principal Investigator - Inma Guash Jordan, MD
Fundación Althaia Manresa
Principal Investigator - Isabel Busquier, MD
Consorcio Hospitalario Provincial de Castellón
Principal Investigator - Jaume Capdevila, MD
Hospital Universitari Vall d'Hebrón
Principal Investigator - Javier Gallego Plazas, MD
Hospital General Universitario de Elche
Principal Investigator - Joan Maurel Santasusana, MD
Hospital Clinic of Barcelona
Principal Investigator - Laura Layos Romero, MD
Hospital Universitari Germans Trias i Pujol de Badalona
Principal Investigator - Marta Martín-Richard, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Principal Investigator - Miguel Nogué, MD
Hospital General de Granollers
Principal Investigator - Núria Rodríguez Salas, MD
Hospital Universitario La Paz
Principal Investigator - Rocio García Carbonero, MD
Hospital Universitario 12 de Octubre
Principal Investigator - Ruth Vera García, MD
Complejo Hospitalario de Navarra
Principal Investigator - Vicente Alonso Orduña, MD
Hospital Miguel Servet
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2015
- Primary completion
- 15 Jul 2019
- Completion
- 4 Feb 2020
- Last update posted
- 3 May 2021
- Registered enrollment
- 180
- Registry id
- NCT02340949
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.